pentylenetetrazole has been researched along with Frontotemporal Dementia in 1 studies
Pentylenetetrazole: A pharmaceutical agent that displays activity as a central nervous system and respiratory stimulant. It is considered a non-competitive GAMMA-AMINOBUTYRIC ACID antagonist. Pentylenetetrazole has been used experimentally to study seizure phenomenon and to identify pharmaceuticals that may control seizure susceptibility.
pentetrazol : An organic heterobicyclic compound that is 1H-tetrazole in which the hydrogens at positions 1 and 5 are replaced by a pentane-1,5-diyl group. A central and respiratory stimulant, it was formerly used for the treatment of cough and other respiratory tract disorders, cardiovascular disorders including hypotension, and pruritis.
Frontotemporal Dementia: The most common clinical form of FRONTOTEMPORAL LOBAR DEGENERATION, this dementia presents with personality and behavioral changes often associated with disinhibition, apathy, and lack of insight.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| García-Cabrero, AM | 1 |
| Guerrero-López, R | 1 |
| Giráldez, BG | 1 |
| Llorens-Martín, M | 1 |
| Avila, J | 1 |
| Serratosa, JM | 1 |
| Sánchez, MP | 1 |
1 other study available for pentylenetetrazole and Frontotemporal Dementia
| Article | Year |
|---|---|
Hyperexcitability and epileptic seizures in a model of frontotemporal dementia.
Topics: Animals; Brain; Calcium-Binding Proteins; Convulsants; Disease Models, Animal; DNA-Binding Proteins; | 2013 |